Evidence map›Paper›PMID 26797799›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Expression of the anti-inflammatory suppressor of cytokine signaling 3 (SOCS3) in human clear cell renal cell carcinoma.

Anja Urbschat, Svenja Stumpf, Jörg Hänze, Patrick Paulus, Thorsten J Maier, Christine Weipert, Rainer Hofmann, Axel Hegele

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. The role of IL-22 in cancer.Medical oncology (Northwood, London, England) · 2024
    Review
  2. Article
  3. [Role of cytokine signal suppressor 3 in the regulatory mechanism of colon cancer invasion and proliferation].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Anja UrbschatDepartment of Urology and Pediatric Urology, University Hospital of the Philipps-University Marburg, Baldinger Strasse, Marburg, Germany. anja.urbschat@staff.uni-marburg.de.
Svenja StumpfDepartment of Urology and Pediatric Urology, University Hospital of the Philipps-University Marburg, Baldinger Strasse, Marburg, Germany.
Jörg HänzeDepartment of Urology and Pediatric Urology, University Hospital of the Philipps-University Marburg, Baldinger Strasse, Marburg, Germany.
Patrick PaulusDepartment of Anesthesiology and Operative Intensive Care Medicine, Kepler University Hospital Linz, Linz, Austria.
Thorsten J MaierDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.
Christine WeipertClinic of Urology and Andrology, Landeskrankenhaus Hall in Tirol, Hall, Austria.
Rainer HofmannDepartment of Urology and Pediatric Urology, University Hospital of the Philipps-University Marburg, Baldinger Strasse, Marburg, Germany.
Axel HegeleDepartment of Urology and Pediatric Urology, University Hospital of the Philipps-University Marburg, Baldinger Strasse, Marburg, Germany.
Philipps University of Marburg · DEAarhus University · DKKepler Universitätsklinikum · ATTirol Kliniken · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oncogenic transcription factor signal transducer and activator of transcription 3 (STAT3) is a cytokine-activated transcription factor controlling inflammation, cell proliferation, survival, and differentiation in normal tissue as well as in tumor growth. One of its most important negative regulators is the suppressor of cytokine signaling 3 (SOCS3). Here, we analyzed SOCS3 and other tumor-associated local immune regulators in human clear cell renal cell carcinoma (ccRCC). Analyses were performed in tumor and adjacent tumor-free healthy renal tissue from 35 patients with ccRCC. For functional analysis, ccRCC Caki-1 cell lines were stimulated with IL-6 and IFNγ in cell culture assays. We observed significantly lower SOCS3 messenger RNA (mRNA) levels in tumor tissue compared to healthy tissue. SOCS3 mRNA strongly correlated within tumor and healthy tissue. Interestingly vice versa, SOCS3 protein levels were significantly higher in tumor tissue than in healthy tissue. IL-22 and IL-22R1 mRNA displayed no differences in tumor and healthy tissue. Stimulation of Caki-1 cells with IFNγ resulted in markedly increased SOCS3 mRNA levels. We conclude that SOCS3 along with STAT3 participates in regulatory mechanisms in ccRCC, which certainly features only one of multiple factors involved but nevertheless merits further attention.

Indexed as

AdultAgedAged, 80 and overCarcinoma, Renal CellCell Line, TumorFemaleGene Expression RegulationHumansInflammationInterferon-gammaInterleukin-22Interleukin-6InterleukinsMaleMiddle AgedRNA, MessengerInterferon-gammaInterleukin-22Interleukin-6InterleukinsRNA, MessengerSOCS3 protein, humanSTAT3 Transcription FactorSuppressor of Cytokine Signaling 3 ProteinClear cell renal cell carcinomaJAK2SOCS3STAT3

Identifiers

PMID26797799
OpenAlexW2258769359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.